Our data showing that loss of CD95 in TNBC cells promotes the remodeling of the immune landscape and triggers the anti-tumor activity of NK cells in a TNBC mouse model raised the question of whether CD95 loss by itself in TNBC cells could actively reprogram the transcriptomic signature of these cells. This evidence concerns the gene FAS and neoplasm.